(Recap of blog post 2) The AbClo device represents an outstanding advancement that aims to revolutionize the non-invasive management of […]
AbClo: The Latest Innovation in Open Abdomen Management – Part 3
Recap of Blog Post #1 AbClo represents a significant advancement in the management of open abdomen cases. Regardless of the […]
Introduction The concept of leaving the abdomen open to manage intra-abdominal pressure and allow for repeated interventions has transformed surgical […]
Since their inception into surgical practice, open abdomens have been a notoriously risky critical care pathway. As with any open […]
With published studies, peer-reviewed data, and real-world results backing AbClo’s efficacy at open abdomen management, this article aims to highlight […]
Dr. João Rezende-Neto is the founder and Chief Medical Officer at AbClo, a minimally invasive, pressure regulated, fascial traction device […]
5 Takeaways In Innovating Healthcare with Chris Bass (ventureLAB Chats Episode 11 with Hilary Kilgour)
5 months ago
The medtech industry is a landscape of high stakes, rigorous research, and transformative potential. In a recent episode of the […]
Part 2: Fascial Closure Achieved Faster With AbClo (3.7 Days vs 6.4 Days) One of AbClo’s most compelling investigations to […]
Part 1: Applying AbClo Early Achieved a 98% Primary Fascial Closure Rate Primary fascial closure rates are one of the […]
How Paul Torreggiani Is Helping Shape the Future of Fascial Closure Devices Through Business Development
10 months ago
Paul Torreggiani’s path to becoming Vice President of Business Development at AbClo—a cutting-edge medical device company—began with a degree in […]